Preliminary proteome analysis of rabbit serum with hepatic failure

Enzyme and Microbial Technology

Volumn 33, Issue 4, 2003, Pages 488-491

  Tien, Chao Chen ^a   Chen, Jau Bin ^a   Wang, Chih Chi ^b   Lee, Wen Chien ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Dimethylnitrosamine; Hepatic failure; Liver fibrosis cirrhosis; Proteome; Serum amyloid A proteins

Indexed keywords

ANIMAL CELL CULTURE; CENTRIFUGATION; ELECTROPHORESIS; GELS; MASS SPECTROMETRY;

HEPATIC FAILURES;

PROTEINS;

ACUTE PHASE PROTEIN; ALBUMIN; AMYLOID PRECURSOR PROTEIN; DIMETHYLNITROSAMINE; PROTEOME; SERUM AMYLOID A; SERUM AMYLOID A 2 PRECURSOR PROTEIN; SERUM AMYLOID A 3 PRECURSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD SAMPLING; CENTRIFUGATION; CONFERENCE PAPER; CONTROLLED STUDY; EXPERIMENTAL MODEL; GEL ELECTROPHORESIS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FIBROSIS; LIVER FUNCTION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PROTEIN ANALYSIS; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEOMICS; RABBIT; SERUM; SUPERNATANT;

ORYCTOLAGUS CUNICULUS;

EID: 0041429222     PISSN: 01410229     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0141-0229(03)00153-4     Document Type: Conference Paper

References (21)

1. Fountoulakis M., Suter L. Proteomic analysis of the rat liver. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 782:2002;197-218.
2. Jung E., Hoogland C., Chiappe D., Sanchez J.C., Hochstrasser D.F. The establishment of a human liver nuclei two-dimensional electrophoresis reference map. Electrophoresis. 21:2002;3483-3487.
3. Seow T.K., Ong S.E., Liang R.C., Ren E.C., Chan L., Ou K.et al. Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, and identification of the separated proteins by mass spectrometry. Electrophoresis. 21:2000;1787-1813.
4. Ou K., Seow T.K., Liang R.C., Ong S.E., Chung M.C. Proteome analysis of a human hepatocellular carcinoma cell line, HCC-M: an update. Electrophoresis. 22:2001;2804-2811.
5. Wirth P.J., Hoang T.N., Benjamin T. Micropreparative immobilized pH gradient two-dimensional electrophoresis in combination with protein microsequencing for the analysis of human liver proteins. Electrophoresis. 16:1995;1946-1960.
6. Lim S.O., Park S.J., Kim W., Park S.G., Kim H.J., Kim Y.I.et al. Proteome analysis of hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 291:2002;1031-1037.
7. Kim J., Kim S.H., Lee S.U., Ha G.H., Kang D.G., Ha N.Y.et al. Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins. Electrophoresis. 23:2002;4142-4156.
8. Liang R.C.M.Y., Neo J.C.H., Lo S.L., Tan G.S., Seow T.K., Chung M.C.M. Proteome database of hepatocellular carcinoma. J. Chromatogr. B. 771:2002;303-328.
9. Ruepp S.U., Tonge R.P., Shaw J., Wallis N., Pognan F. Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol. Sci. 65:2002;135-150.
10. Newsholme S.J., Maleeff B.F., Steiner S., Anderson N.L., Schwartz L.W. Two-dimensional electrophoresis of liver proteins: characterization of a drug-induced hepatomegaly in rats. Electrophoresis. 21:2000;2122-2128.
11. Man W.J., White I.R., Bryant D., Bugelski P., Camilleri P., Cutler P. Protein expression analysis of drug-mediated hepatotoxicity in the Sprague-Dawley rat. Proteomics. 2:2002;1577-1585.
12. Steiner S., Gatlin C.L., Lennon J.J., McGrath A.M., Aponte A.M., Makusky A.J.et al. Proteomics to display lovastatin-induced protein and pathway regulation in rat liver. Electrophoresis. 21:2000;2129-2137.
13. Fountoulakis M., Berndt P., Boelsterli U.A., Crameri F., Winter M., Albertini S.et al. Two-dimensional database of mouse liver proteins: changes in hepatic protein levels following treatment with acetaminophen or its nontoxic regioisomer 3-acetamidophenol. Electrophoresis. 21:2000;2148-2161.
14. Tonge R., Shaw J., Middleton B., Rowlinson R., Rayner S., Young J.et al. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics. 1:2001;377-396.
15. Kennedy S. Proteomic profiling from human samples: the body fluid alternative. Toxicol. Lett. 120:2001;379-384.
16. Steel L.F., Mattu T.S., Mehta A., Hebestreit H., Dwek R., Evans A.A.et al. A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma. Dis. Markers. 17:2001;179-189.
17. Matsuda Y., Matsumoto K., Ichida T., Nakamura T. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J. Biochem. 118:1995;643-649.
18. Matsuda Y., Matsumoto K., Yamada A., Ichida T., Asakura H., Komoriya Y. et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology. 26:1997;81-89.
19. Kaido T., Seto S.I., Yamaoka S., Yoshikawa A., Imamura M. Perioperative continuous hepatocyte growth factor supply prevents postoperative liver failure in rats with liver cirrhosis. J. Surg. Res. 74:1998;173-178.
20. Benditt E.P., Ericksen N., Hanson R.H. Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein. Proc. Natl. Acad. Sci. U.S.A. 76:1979;4092-4096.
21. de Beer M.C., de Beer F.C., Gerardot C.J., Cecil D.R., Webb N.R., Goodson M.L.et al. Structure of the mouse Saa4 gene and its linkage to the serum amyloid A gene family. Genomics. 34:1996;139-142.